Novo Nordisk has announced that it's cutting the price of pre-filled insulin pens and vials by up to 75 percent for people living with diabetes starting in January 2024. 

"We have been working to develop a sustainable path forward that balances patient affordability, market dynamics, and evolving policy changes," said Steve Albers, senior vice president of market access and public affairs at Novo Nordisk, Inc. "Novo Nordisk remains committed to ensuring patients living with diabetes can afford our insulins, a responsibility we take seriously."

Earlier this month, rival drugmaker Eli Lilly announced plans to reduce insulin prices by 70 percent and cap patient out-of-pocket costs for insulin at $35 per month. 

The Biden administration has put public pressure on drugmakers to make medically necessary insulins more affordable. Novo Nordisk notably did not put a cap on out-of-pocket expenses. 

Novo Nordisk will lower the price for four different brands, including NovoLog® and NovoLog® Mix 70/30 by 75 percent and Novolin® and Levemir® by 65 percent. 

Share:
More In Business
Looking Back at the History of the Minivan
Last year, the minivan only made up 1.8% of auto sales but more and more people are interested in purchasing the comfortable, multi-seater. Cheddar News looks back at the evolution and history of the minivan.
How to Go Viral on TikTok
With more than 150 million Americans on the platform each month, TikTok can help businesses, brands, and bands get attention and stand out.
Survey: Americans Are More Worried About Credit Access
Americans said credit was harder to access last month, according to a survey from the New York branch of the Federal Reserve. The March Survey of Consumer Expectations found that “respondents were more pessimistic about future credit availability as well, with the share of households expecting it will be harder to obtain credit a year from now also rising.”
Load More